Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. chlamydia
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Chlamydia Articles & Analysis

12 news found

Chiricahua Community Health Centers, Inc., Launches STI Testing Program for Women with Same-Day Results

Chiricahua Community Health Centers, Inc., Launches STI Testing Program for Women with Same-Day Results

CCHCI among first healthcare providers in the nation to adopt new handheld PCR technology to detect gonorrhea, chlamydia and trichomoniasis in a single visit. Chiricahua Community Health Centers, Inc. ...

ByVisby Medical, Inc.


Urgent Care For Children Collaborates With Visby Medical To Provide New Gold Standard Diagnostic For Sexually Transmitted Infections

Urgent Care For Children Collaborates With Visby Medical To Provide New Gold Standard Diagnostic For Sexually Transmitted Infections

Visby Medical, Inc. an innovative diagnostic company, today announced its agreement with Urgent Care for Children (UC4C) to offer the company’s new Sexual Health Click Test to patients for the detection of sexually transmitted infections (STIs) in female patients 14 years of age and older. The device can detect chlamydia, gonorrhea, and trichomoniasis, three of the most ...

ByVisby Medical, Inc.


Evofem Biosciences to Report Fourth Quarter and Year-End 2021 Results and Provide Corporate Update on Thursday, March 3, 2022

Evofem Biosciences to Report Fourth Quarter and Year-End 2021 Results and Provide Corporate Update on Thursday, March 3, 2022

About Evofem Biosciences Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (chlamydia and gonorrhea). The Company's first FDA-approved product, Phexxi® ...

ByEvofem Biosciences, Inc.


Evofem Biosciences Announces Record Net Sales and Phexxi Prescriptions in Q4 2021

Evofem Biosciences Announces Record Net Sales and Phexxi Prescriptions in Q4 2021

About Evofem Biosciences Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products and product candidates to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (chlamydia and gonorrhea). The Company's first ...

ByEvofem Biosciences, Inc.


Phexxi Access to Expand under New Government Guidance Stating Insurers Must Cover FDA-approved Contraceptives with No Out-of-Pocket Costs to Women

Phexxi Access to Expand under New Government Guidance Stating Insurers Must Cover FDA-approved Contraceptives with No Out-of-Pocket Costs to Women

About Evofem Biosciences Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products and product candidates to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (chlamydia and gonorrhea). The Company's first ...

ByEvofem Biosciences, Inc.


Evofem Biosciences to Present at H.C. Wainwright BioConnect Conference

Evofem Biosciences to Present at H.C. Wainwright BioConnect Conference

Chief Executive Officer Saundra Pelletier will provide an update on the commercialization of Evofem's hormone-free contraceptive Phexxi® (lactic acid, citric acid and potassium bitartrate) as well as the Company's pipeline, including the ongoing Phase 3 clinical trial evaluating EVO100 for the prevention of chlamydia and gonorrhea in women and the recently announced ...

ByEvofem Biosciences, Inc.


Evofem Biosciences and Orion Biotechnology Launch Collaboration to Develop MPT Product Candidate to Include HIV Prevention

Evofem Biosciences and Orion Biotechnology Launch Collaboration to Develop MPT Product Candidate to Include HIV Prevention

Top-line data is expected from Evofem's pivotal Phase 3 trial for the prevention of chlamydia and gonorrhea in women in the second half of 2022. 1 Veazey et al. ...

ByEvofem Biosciences, Inc.


Evofem Biosciences Expects Record High Phexxi Prescriptions and Strong Net Revenue Growth in Fourth Quarter 2021

Evofem Biosciences Expects Record High Phexxi Prescriptions and Strong Net Revenue Growth in Fourth Quarter 2021

About Evofem Biosciences Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products and product candidates to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (chlamydia and gonorrhea). The Company's first ...

ByEvofem Biosciences, Inc.


Evofem Biosciences to Adjourn Special Meeting of Stockholders on December 8, 2021

Evofem Biosciences to Adjourn Special Meeting of Stockholders on December 8, 2021

About Evofem Biosciences Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products and product candidates to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (chlamydia and gonorrhea). The Company's first ...

ByEvofem Biosciences, Inc.


Clinical Data of The Visby Medical Sexual Health Click Test Published in Journal of the American Sexually Transmitted Diseases Association

Clinical Data of The Visby Medical Sexual Health Click Test Published in Journal of the American Sexually Transmitted Diseases Association

Visby Medical™, a leading medical diagnostic company, today announced results from the cross-sectional single visit patient outcomes and implementation study, which evaluated self-collected vaginal swab samples from 55 women using the Visby Medical Sexual Health Click Test for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV). ...

ByVisby Medical, Inc.


Abbott Molecular distribution of ELITechGroup products will expand distribution channels

Abbott Molecular distribution of ELITechGroup products will expand distribution channels

Other products included in the agreement will focus on the expanding need to test for additional sexually transmitted infections beyond Chlamydia and Gonorrhea. The agreement will provide a broader based distribution of ELITechGroup MGB Alert Analyte Specific Reagents. ...

ByELITechGroup


Psittacosis and Chlamydia psittaci Exposed in New Online Video

Psittacosis and Chlamydia psittaci Exposed in New Online Video

The latest educational video discusses psittacosis and Chlamydia psittaci. Psittacosis is an infectious disease usually transmitted to humans from birds in the parrot family as well as from turkeys and pigeons. ...

ByCochrane & Associates, LLC

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT